These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 9588657)

  • 1. Effects of the ATP-sensitive K channel opener nicorandil on the QT interval and the effective refractory period in patients with congenital long QT syndrome. Investigator Group for K-Channel Openers and Arrhythmias.
    Aizawa Y; Uchiyama H; Yamaura M; Nakayama T; Arita M
    J Electrocardiol; 1998 Apr; 31(2):117-23. PubMed ID: 9588657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicorandil suppresses a hump on the monophasic action potential and torsade de pointes in a patient with idiopathic long QT syndrome.
    Chinushi M; Aizawa Y; Furushima H; Inuzuka H; Ojima K; Shibata A
    Jpn Heart J; 1995 Jul; 36(4):477-81. PubMed ID: 7474363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early afterdepolarization abolished by potassium channel opener in a patient with idiopathic long QT syndrome.
    Sato T; Hata Y; Yamamoto M; Morita H; Mizuo K; Yamanari H; Saito D; Ohe T
    J Cardiovasc Electrophysiol; 1995 Apr; 6(4):279-82. PubMed ID: 7647953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of repolarization abnormalities by a K+ channel opener in the LQT1 form of congenital long-QT syndrome.
    Shimizu W; Kurita T; Matsuo K; Suyama K; Aihara N; Kamakura S; Towbin JA; Shimomura K
    Circulation; 1998 Apr; 97(16):1581-8. PubMed ID: 9593563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the ATP-sensitive K⁺ channel opener nicorandil in a canine model of proarrhythmia.
    Watanabe I; Okumura Y; Ohkubo K; Nagashima K; Mano H; Sonoda K; Kofune M; Kunimoto S; Kasamaki Y; Hirayama A
    Int Heart J; 2011; 52(5):318-22. PubMed ID: 22008444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a K(+) channel opener to reduce transmural dispersion of repolarization and prevent torsade de pointes in LQT1, LQT2, and LQT3 models of the long-QT syndrome.
    Shimizu W; Antzelevitch C
    Circulation; 2000 Aug; 102(6):706-12. PubMed ID: 10931813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicorandil, a potassium channel opener, abolished torsades de pointes in a patient with complete atrioventricular block.
    Watanabe O; Okumura T; Takeda H; Nakamura W; Segawa K; Ito H; Yoshimoto N
    Pacing Clin Electrophysiol; 1999 Apr; 22(4 Pt 1):686-8. PubMed ID: 10234727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inherited long QT syndrome: from ion channel to bedside.
    Vincent GM; Timothy K; Fox J; Zhang L
    Cardiol Rev; 1999; 7(1):44-55. PubMed ID: 10348966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic effects of potassium channel openers in rhythm abnormalities related to delayed repolarization.
    Carlsson L; Abrahamsson C; Drews L; Duker G
    Circulation; 1992 Apr; 85(4):1491-500. PubMed ID: 1555289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of atropine on QT prolongation and torsade de pointes induced by intracoronary acetylcholine in the long QT syndrome.
    Furushima H; Niwano S; Chinushi M; Yamaura M; Taneda K; Washizuka T; Aizawa Y
    Am J Cardiol; 1999 Mar; 83(5):714-8. PubMed ID: 10080424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular biology of the long QT syndrome: impact on management.
    Priori SG; Napolitano C; Paganini V; Cantù F; Schwartz PJ
    Pacing Clin Electrophysiol; 1997 Aug; 20(8 Pt 2):2052-7. PubMed ID: 9272507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicorandil abolished repolarisation alternans in a patient with idiopathic long QT syndrome.
    Fujimoto Y; Morita H; Fukushima KK; Ohe T
    Heart; 1999 Nov; 82(5):e8. PubMed ID: 10525528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade des pointes in LQT2 and LQT3 models of the long-QT syndrome.
    Shimizu W; Antzelevitch C
    Circulation; 1997 Sep; 96(6):2038-47. PubMed ID: 9323097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of nicorandil, a potassium channel opener, on idiopathic ventricular tachycardia.
    Kobayashi Y; Miyata A; Tanno K; Kikushima S; Baba T; Katagiri T
    J Am Coll Cardiol; 1998 Nov; 32(5):1377-83. PubMed ID: 9809951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological treatment of acquired QT prolongation and torsades de pointes.
    Thomas SH; Behr ER
    Br J Clin Pharmacol; 2016 Mar; 81(3):420-7. PubMed ID: 26183037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beat-by-beat QT interval variability, but not QT prolongation per se, predicts drug-induced torsades de pointes in the anaesthetised methoxamine-sensitized rabbit.
    Jacobson I; Carlsson L; Duker G
    J Pharmacol Toxicol Methods; 2011; 63(1):40-6. PubMed ID: 20451633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
    Lu HR; Yan GX; Gallacher DJ
    J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined pharmacological block of I(Kr) and I(Ks) increases short-term QT interval variability and provokes torsades de pointes.
    Lengyel C; Varró A; Tábori K; Papp JG; Baczkó I
    Br J Pharmacol; 2007 Aug; 151(7):941-51. PubMed ID: 17533421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mexiletine Shortens the QT Interval in Patients With Potassium Channel-Mediated Type 2 Long QT Syndrome.
    Bos JM; Crotti L; Rohatgi RK; Castelletti S; Dagradi F; Schwartz PJ; Ackerman MJ
    Circ Arrhythm Electrophysiol; 2019 May; 12(5):e007280. PubMed ID: 31006312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reckless administration of QT interval-prolonging agents in elderly patients with drug-induced torsade de pointes.
    Jackobson G; Carmel NN; Lotan D; Kremer A; Justo D
    Z Gerontol Geriatr; 2018 Jan; 51(1):41-47. PubMed ID: 27878411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.